AXSAIN

This brand name is authorized in Ireland, United Kingdom

Active ingredients

The drug AXSAIN contains one active pharmaceutical ingredient (API):

1 Capsaicin UNII S07O44R1ZM - CAPSAICIN

Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides. Read about Capsaicin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AXSAIN Cream	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M02AB01	Capsaicin	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AB Capsaicin and similar agents
Discover more medicines within M02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 22469
Country: IE	Health Products Regulatory Authority	Identifier(s): 50905